glp-1 agonists blindness risk List of approved and pending medications Mounjaro, Zepbound: Generic GLP-1 Drugs

in Spain, its current prevalence ranges between 2833%11,12 and it is a recognized as a cardiovascular risk factor and increases the mortality in this population.1315 Furthermore, in patients with DM2 and advanced CKD there are limitations in the prescription of certain antihyperglycemic drugs (e.g., metformin or sulfonylureas) and there is an increased risk of hypoglycemia with antihyperglycemic treatment,16 a complication that is associated with increased cardiovascular risk17 and hinders the achievement of glycemic control targets

Lancet Lond Engl

However, due to intense competition in the local markets for insulin, consumer penetration for their products must be achieved through constant work and effort

Can This Drink Replace Coffee

Journal of applied physiology (Bethesda, Md